DIFFERENTIAL TRANSIMPEDANCE AMPLIFIER
    172.
    发明申请
    DIFFERENTIAL TRANSIMPEDANCE AMPLIFIER 审中-公开
    差分放大放大器

    公开(公告)号:US20170077884A1

    公开(公告)日:2017-03-16

    申请号:US15311122

    申请日:2015-06-11

    Inventor: Sung Min PARK

    Abstract: Disclosed is a differential transimpedance amplifier. The differential transimpedance amplifier includes a common gate amplifier configured to receive an electrical signal from an input node, and a common source amplifier configured to have a feedback resistor and receive the electrical signal form the input node, wherein an output signal of the common gate amplifier and an output signal of the common source amplifier form a differential signal pair.

    Abstract translation: 公开了一种差分跨阻放大器。 差分跨阻放大器包括:公共栅极放大器,被配置为从输入节点接收电信号;以及公共源极放大器,被配置为具有反馈电阻器并从输入节点接收电信号,其中公共栅极放大器的输出信号 并且公共源极放大器的输出信号形成差分信号对。

    COMPOUND BASED ON CYANINE SCAFFOLD FOR DIAGNOSIS SEPSIS BY SELECTIVELY DETECT GLUTATHIONE
    174.
    发明申请
    COMPOUND BASED ON CYANINE SCAFFOLD FOR DIAGNOSIS SEPSIS BY SELECTIVELY DETECT GLUTATHIONE 有权
    通过选择性检测GLUTATHIONE的基于CYANINE SCAFFOLD进行诊断的化合物

    公开(公告)号:US20160083344A1

    公开(公告)日:2016-03-24

    申请号:US14663990

    申请日:2015-03-20

    Abstract: The present invention relates to a compound based on cyanine scaffold for diagnosing sepsis by selectively detecting glutathione. The compound based on cyanine scaffold according to the present invention has the advantages of maintaining its structure in intracellular environment and of reacting selectively to glutathione only among many amino acids containing thiol group (R—SH) such as cysteine, homocysteine, and glutathione, to produce changes in absorption or fluorescence spectrum, making the compound useful for the detection of in vivo glutathione in biosamples and also for the diagnosis of sepsis characteristically displaying the changes of glutathione concentration.

    Abstract translation: 本发明涉及一种基于花青支架的化合物,用于通过选择性检测谷胱甘肽来诊断败血症。 根据本发明的基于花青支架的化合物具有将其结构保持在细胞内环境中,并且仅在许多含巯基(R-SH)的氨基酸(如半胱氨酸,高半胱氨酸和谷胱甘肽)中选择性地与谷胱甘肽反应, 产生吸收或荧光光谱的变化,使得该化合物可用于检测生物样品中的体内谷胱甘肽,并且还用于诊断特征性显示谷胱甘肽浓度变化的败血症。

    METHOD FOR PROPAGATING NETWORK MANAGEMENT DATA FOR ENERGY-EFFICIENT IOT NETWORK MANAGEMENT AND ENERGY-EFFICIENT IOT NODE APPARATUS
    175.
    发明申请
    METHOD FOR PROPAGATING NETWORK MANAGEMENT DATA FOR ENERGY-EFFICIENT IOT NETWORK MANAGEMENT AND ENERGY-EFFICIENT IOT NODE APPARATUS 有权
    用于传播网络管理数据的能源效率网络管理和能源效率节点设备的方法

    公开(公告)号:US20160006814A1

    公开(公告)日:2016-01-07

    申请号:US14748334

    申请日:2015-06-24

    CPC classification number: H04L41/0833

    Abstract: A method for propagating network management data for energy-efficient internet of things network management and an energy-efficient internet of things node apparatus are disclosed herein. The method includes dividing a plurality of sub-nodes into at least two terminal sub-nodes and the remaining intermediate sub-nodes, and determining a transmission path so that the terminal sub-nodes and the intermediate sub-nodes satisfy an acyclic graph condition, dividing the plurality of pieces of data of network management information into at least two data groups, and transmitting one of the at least two data groups to one of the terminal sub-nodes respectively, transmitting the data of the received data group to adjacent intermediate sub-nodes, performing network coding on selected two pieces of data, transmitting the network-coded data to the at least two intermediate adjacent sub-nodes, and decoding the received network-coded data using previously held data.

    Abstract translation: 本文公开了一种用于传播东西网络管理和节点装置的节能因特网的节能互联网的网络管理数据的方法。 该方法包括将多个子节点划分成至少两个终端子节点和其余的中间子节点,并且确定传输路径,使得终端子节点和中间子节点满足非循环图状态, 将网络管理信息的多条数据划分为至少两个数据组,并将至少两个数据组中的一个分别发送到终端子节点之一,将接收到的数据组的数据发送到相邻的中间子 节点,对所选择的两条数据执行网络编码,将网络编码的数据发送到至少两个中间相邻子节点,以及使用先前保存的数据对接收到的网络编码数据进行解码。

    BUFFER CACHE APPARATUS, JOURNALING FILE SYSTEM AND JOURNALING METHOD FOR INCORPORATING JOURNALING FEATURES WITHIN NON-VOLATILE BUFFER CACHE
    178.
    发明申请
    BUFFER CACHE APPARATUS, JOURNALING FILE SYSTEM AND JOURNALING METHOD FOR INCORPORATING JOURNALING FEATURES WITHIN NON-VOLATILE BUFFER CACHE 审中-公开
    缓存缓存设备,日志文件系统和在非易失性缓冲区缓存中加入日志功能的日志方法

    公开(公告)号:US20140297918A1

    公开(公告)日:2014-10-02

    申请号:US13862597

    申请日:2013-04-15

    CPC classification number: G06F12/0804 G06F11/141 G06F11/1474 G06F12/0871

    Abstract: Disclosed herein are a buffer cache apparatus, a journaling file system, and a journaling method capable of incorporating journaling features based on nonvolatile memory. The buffer cache apparatus provides a data buffering function between a central processing unit (CPU) and storage. The buffer cache apparatus includes a plurality of cache blocks and a journal management unit. The plurality of cache blocks are configured as volatile or nonvolatile memory devices. The journal management unit maintains states of freezing for write-protecting dirty up-to-date cache blocks among the plurality of cache blocks.

    Abstract translation: 本文公开了一种能够结合基于非易失性存储器的日记功能的缓冲器缓存装置,日志文件系统和日志记录方法。 缓冲缓存装置在中央处理单元(CPU)和存储器之间提供数据缓冲功能。 缓冲存储器装置包括多个缓存块和日记管理单元。 多个高速缓存块被配置为易失性或非易失性存储器件。 日记管理单元维护在多个高速缓存块之间进行写保护的脏保护最新缓存块的冻结状态。

    METHOD FOR CULTURING CARDIAC PROGENITOR CELLS AND USE OF CARDIAC PROGENITOR CELLS
    180.
    发明申请
    METHOD FOR CULTURING CARDIAC PROGENITOR CELLS AND USE OF CARDIAC PROGENITOR CELLS 审中-公开
    培养心脏病原体细胞的方法和使用心脏原细胞细胞

    公开(公告)号:US20130295060A1

    公开(公告)日:2013-11-07

    申请号:US13886663

    申请日:2013-05-03

    Abstract: Disclosed is a method for culturing myocardium-resident cardiac progenitor cells, comprising: embedding myocardial fragments into hydrogel; culturing the myocardial fragment into hydrogel; degrading only the hydrogel to recover cardiac progenitor cells grown out of the myocardial fragment to the hydrogel; and amplifying the cardiac progenitor cells in vitro. Also, the cardiac progenitor cells, a method for differentiating the same, and the use thereof as cell therapeutic agent for heart diseases are provided. In addition to possessing the potential to differentiate into cardiomyocytes, osteoblasts, adipocytes, chondrocytes, vascular endothelial cells, smooth muscle cells, neural cells, and skeletal muscle cells, the myocardium-resident cardiac progenitor cells can spontaneously differentiate into cardiomyocytes even in the absence of a special differentiation inducing agent. Thus, the cardiac progenitor cells can be used to produce bio-active medicines such as cell therapeutics and tissue engineering therapeutics with high industrial applicability.

    Abstract translation: 公开了一种培养心肌驻留心脏祖细胞的方法,包括:将心肌片段包埋在水凝胶中; 将心肌片段培养成水凝胶; 仅降解水凝胶以将从心肌片段生长的心脏祖细胞回收至水凝胶; 并在体外扩增心脏祖细胞。 此外,提供了心脏祖细胞,其分化方法及其作为心脏病的细胞治疗剂的用途。 除了具有分化成心肌细胞,成骨细胞,脂肪细胞,软骨细胞,血管内皮细胞,平滑肌细胞,神经细胞和骨骼肌细胞的潜力之外,心肌驻留的心脏祖细胞也可以自发分化成心肌细胞,即使没有 一种特殊的分化诱导剂。 因此,心脏祖细胞可用于生产具有高工业应用性的生物活性药物,例如细胞治疗剂和组织工程治疗剂。

Patent Agency Ranking